Position in VYGR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$48,755
+$37,640 QoQ
Shares Held
12,631
+564.8% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VYGR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026nVerses Capital, LLC holds $2,897,783 across 16 Biotechnology names. VYGR ranks #15 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
8,978 | $430,674 | |
| 2 | VCEL |
Vericel Corp
|
12,842 | $413,127 | |
| 3 | INVA |
Innoviva, Inc.
|
15,888 | $370,190 | |
| 4 | ARCT |
Arcturus Therapeutics Holdings Inc.
|
38,236 | $295,181 | |
| 5 | FTRE |
Fortrea Holdings Inc.
|
24,379 | $229,650 | |
| 6 | SVRA |
Savara Inc
|
39,858 | $217,624 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
22,364 | $201,499 | |
| 8 | OMER |
Omeros Corp
|
14,404 | $152,106 |
All Filings in VYGR
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $48,755 | 12,631 | Shares | Sole | 2026-05-13 | |
| 2024-09-30 | $11,115 | 1,900 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $791 | 100 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||